M

Milestone Pharmaceuticals
D

MIST

2.02800
USD
-0.03
(-1.55%)
مغلق
حجم التداول
5,213
الربح لكل سهم
-1
العائد الربحي
-
P/E
-3
حجم السوق
108,148,997
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Milestone Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).